发明名称 |
TRICYCLIC THERAPEUTICS FOR CHEMOKINE MEDIATED DISEASES |
摘要 |
The invention provides therapeutic and biological uses of chemokine-receptor-binding compounds (including chemokine receptor ligands such as chemokine receptor agonists or antagonists), such as tricyclic phenanthrene derivatives, including uses in the treatment of disease states mediated by chemokines or chemokine receptors. The relevant chemokines may for example be monocyte chemoattractant protein-one (MCP-1) or interleukin-8 (IL-8), and the relevant chemokine receptors may for example be corresponding chemokine receptors (CCR-2, CCR-4, CXCR-1, and CXCR-2). In other aspects, the invention provides corresponding pharmaceutical compositions and therapeutic methods. In one aspect, for example, the invention provides for the use of phenanthrene-9,10-dione in the treatment of multiple sclerosis. |
申请公布号 |
WO0245702(A3) |
申请公布日期 |
2003.01.03 |
申请号 |
WO2001CA01748 |
申请日期 |
2001.12.05 |
申请人 |
CHEMOKINE THERAPEUTICS CORPORATION;SAXENA, GEETA;TUDAN, CHRISTOPHER, R.;SALARI, HASSAN |
发明人 |
SAXENA, GEETA;TUDAN, CHRISTOPHER, R.;SALARI, HASSAN |
分类号 |
A61K31/00;A61K31/015;A61K31/11;A61K31/122;A61K31/473;A61P1/04;A61P9/10;A61P11/00;A61P17/06;A61P19/02;A61P25/28;A61P29/00;A61P31/02;A61P33/06;A61P37/00 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|